Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4db4f4bdd602a36a72b2589a46da0b2d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N47-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-265 |
filingDate |
2012-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef623d9db76f9a69a4e4e9bdcf01da68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfd85718af9b43172f40aa1bbddf4795 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_540dbc9e22bcaf4284a599fb12200893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67cc0bc7e369b461847ffefccbffd5d0 |
publicationDate |
2015-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MX-2013014395-A |
titleOfInvention |
LABIL LIPOPHILIC PROFARMACES TO THE ACID OF CHEMOTHERAPEUTIC AGENTS AGAINST CANCER. |
abstract |
The present application describes an acid-labile lipophilic molecular conjugate of the anti-cancer chemotherapeutic agents and methods to reduce or substantially eliminate the side effects of chemotherapy associated with the administration of an anti-cancer chemotherapeutic agent to a patient in need thereof. |
priorityDate |
2011-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |